Sanjivani Parenteral

Mumbai, India Founded: 1997 • Age: 29 yrs
Generic injectables, oral solids, and sterile powders are manufactured.
Annual revenue $8.1M Latest available
Total funding - Funding intelligence
Employees 40 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Sanjivani Parenteral

Sanjivani Parenteral is a company based in Mumbai (India) founded in 1997. The company has 40 employees as of March 31, 2024.

  • Headquarter Mumbai, India
  • Employees 40 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Sanjivani Paranteral Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $8.14 M (USD)
    29.57
    as on Mar 31, 2025
  • Net Profit
    $947.75 K (USD)
    31.34
    as on Mar 31, 2025
  • EBITDA
    $1.17 M (USD)
    35.45
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    40

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sanjivani Parenteral

Sanjivani Parenteral is a publicly listed company on the BSE with ticker symbol SANJIVIN in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BSE · Ticker: SANJIVIN · Sector: Health technology · India

Funding Insights of Sanjivani Parenteral

Premium access

Detailed funding history for Sanjivani Parenteral

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sanjivani Parenteral

Investments
Premium access

Investment portfolio details for Sanjivani Parenteral

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sanjivani Parenteral

Premium access

Detailed financials for Sanjivani Parenteral

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sanjivani Parenteral Comparisons

Sanjivani Parenteral Primary company
Description
Generic injectables, oral solids, and sterile powders are ma...
Location
Mumbai, India
Founded Year
1997
Annual Revenue
$8.14 M (USD)
Net Profit
$947.75 K (USD)
EBITDA
$1.17 M (USD)
Employees
40
As of 2024
Premium access

Peer comparison for Sanjivani Parenteral

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sanjivani Parenteral

Premium access

Detailed competitors of Sanjivani Parenteral

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sanjivani Parenteral

Premium access

Complete news archive for Sanjivani Parenteral

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjivani Parenteral

Sanjivani Parenteral was founded in 1997.

Sanjivani Parenteral is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Mar 31, 2024, the latest employee count at Sanjivani Parenteral is 40.

Annual revenue of Sanjivani Parenteral is $8.14M as on Mar 31, 2025.

Sanjivani Parenteral was established in 1997 in Mumbai, India, as a generic pharmaceutical manufacturer. Injectables are produced, including analgesics, antibiotics, antidiabetics, sedatives, cardiovascular, and central nervous system products. Facilities are maintained for small volume parenterals, oral solid dosage forms, and sterile powders to support operations in the Indian market.

Yes, Sanjivani Parenteral is publicly traded on BSE under the ticker symbol SANJIVIN.

The ticker symbol of Sanjivani Parenteral is SANJIVIN on BSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available